PHARMAIDS PHARMACEUTICALS LTD. is adopting a new line of business in the Contract Research and Manufacturing Services (CRAMS) domain, which includes product discovery, research, development, manufacturing, testing, and analytical services in the biotechnology, pharmaceuticals, devices, and nutritional products fields. The expected benefits include diversification of revenue streams, enhanced market presence, innovation and research opportunities, strategic collaboration, increased client base, and long-term growth potential. The estimated initial investment in the new line of business is approximately Rs. 53,00,00,000.